Not every weight-loss patient is trying to lose 50 pounds. Some patients are at a reasonable weight but the composition of that weight is wrong — too much fat (particularly visceral abdominal fat), not enough muscle, and a body that doesn't look or function the way it should despite reasonable diet and training. For these patients, the question isn't "how do I lose 50 pounds" — it's "how do I shift the ratio of what I'm carrying."
Peptide-based weight loss works on this problem differently than GLP-1 or HCG. Rather than driving overall caloric restriction and general weight loss, peptide protocols work through the growth hormone axis and related signaling systems to specifically affect body composition — preserving lean muscle, mobilizing fat (particularly visceral fat), supporting metabolic function, and improving recovery so training produces better results.
This is the path for patients whose primary issue isn't general overweight — it's stubborn abdominal fat, poor body composition, metabolic shifts of perimenopause or andropause, or the gradual body composition decline of aging. It pairs well with the broader Holistic Solutions toolkit (hormone optimization, dietary support, training guidance) and produces a different kind of result than GLP-1.
Each of these peptides works on the GH/IGF-1 axis or related pathways to affect body composition. The specific protocol depends on what your case calls for.
The conservative starting point. A GHRH analog that signals your pituitary to produce more of your own growth hormone in natural pulses. Supports sleep, recovery, modest body composition shifts, and overall healthy aging. Long-established adult clinical use. Often the right first step for patients exploring GH-axis support.
The more aggressive GH-axis stack. Combines a modified GHRH (CJC-1295) with a selective GHRP (ipamorelin) for stronger growth hormone release through two complementary pathways. Better for patients with specific body composition goals or those who've used sermorelin and want to step up.
The specialty peptide for visceral fat — the deep abdominal fat surrounding organs that drives metabolic risk and won't respond to diet and exercise. FDA-approved as Egrifta for HIV-related lipodystrophy, used off-label for visceral adiposity. The strongest single tool for stubborn belly fat.
Patients often ask whether they should pursue peptides or GLP-1. The honest answer is that they do different things — and for some patients, the combination is the right answer. Here's how the approaches compare.
Work by reducing appetite and slowing gastric emptying, producing caloric deficit and overall weight loss across both visceral and subcutaneous fat. Strong total-weight reduction. Less specific to body composition. Best for patients with significant weight to lose where the scale number is the primary metric.
Work through the GH/IGF-1 axis to mobilize fat (particularly visceral), preserve lean mass, and improve recovery. Less impact on overall scale weight; more impact on fat-to-muscle ratio and body composition. Best for patients whose primary issue is composition rather than absolute weight, or for patients pairing with lifestyle changes.
Book a free consultation. Dr. Dubroff will tell you whether peptide-based body composition is the right path — or whether GLP-1, HCG, or a combination would serve you better.